8-41822335-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000265709.14(ANK1):​c.127-64198A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.749 in 152,102 control chromosomes in the GnomAD database, including 43,486 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.75 ( 43486 hom., cov: 31)

Consequence

ANK1
ENST00000265709.14 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.274

Publications

4 publications found
Variant links:
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]
ANK1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
  • hereditary spherocytosis type 1
    Inheritance: AR, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.782 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000265709.14. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
NM_001142446.2
c.127-64198A>G
intron
N/ANP_001135918.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
ENST00000265709.14
TSL:1
c.127-64198A>G
intron
N/AENSP00000265709.8
ANK1
ENST00000705521.1
c.127-64198A>G
intron
N/AENSP00000516136.1

Frequencies

GnomAD3 genomes
AF:
0.750
AC:
113926
AN:
151984
Hom.:
43474
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.790
Gnomad AMI
AF:
0.690
Gnomad AMR
AF:
0.768
Gnomad ASJ
AF:
0.752
Gnomad EAS
AF:
0.298
Gnomad SAS
AF:
0.771
Gnomad FIN
AF:
0.688
Gnomad MID
AF:
0.778
Gnomad NFE
AF:
0.763
Gnomad OTH
AF:
0.760
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.749
AC:
113992
AN:
152102
Hom.:
43486
Cov.:
31
AF XY:
0.742
AC XY:
55165
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.790
AC:
32760
AN:
41488
American (AMR)
AF:
0.768
AC:
11732
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.752
AC:
2612
AN:
3472
East Asian (EAS)
AF:
0.298
AC:
1539
AN:
5166
South Asian (SAS)
AF:
0.771
AC:
3711
AN:
4816
European-Finnish (FIN)
AF:
0.688
AC:
7263
AN:
10562
Middle Eastern (MID)
AF:
0.782
AC:
230
AN:
294
European-Non Finnish (NFE)
AF:
0.763
AC:
51908
AN:
67998
Other (OTH)
AF:
0.761
AC:
1608
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1367
2733
4100
5466
6833
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
846
1692
2538
3384
4230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.752
Hom.:
11138
Bravo
AF:
0.754
Asia WGS
AF:
0.600
AC:
2092
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.8
DANN
Benign
0.45
PhyloP100
-0.27
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4466386; hg19: chr8-41679853; API